Kewalramani Reshma

Track record

How each disclosed position did against the S&P ~6 months later

The outcome curve and every position's resultPro →

+23.9%

median move per position

+9.9%

S&P 500 median, same spans

1 of 1

beat the S&P ~6mo later

Disclosed positions

Estimated from their latest filings — positions may have changed since

Estimated positions from their latest filingsPro →

Activity

Open-market buy & sell volume

BuySell

Total +$3.90M bought · −$19.74M sold

All filings on record

Every Form 4 transaction we track for this filer

All10Buys0Sells10

Stock	Transaction	Date	~6mo vs S&P
VRTXVERTEX PHARMACEUTICALS INC / MA	Sell $857.2K · 1,725 sh	2026-02-27	—
VRTXVERTEX PHARMACEUTICALS INC / MA	Sell $2.97M · 5,995 sh	2026-02-27	—
VRTXVERTEX PHARMACEUTICALS INC / MA	Sell $7.72M · 15,580 sh	2026-02-27	—
VRTXVERTEX PHARMACEUTICALS INC / MA	Sell $1.73M · 3,498 sh	2026-02-27	—
VRTXVERTEX PHARMACEUTICALS INC / MA	Sell $1.24M · 2,520 sh	2026-02-27	—
VRTXVERTEX PHARMACEUTICALS INC / MA	Sell $466.2K · 949 sh	2026-02-27	—
VRTXVERTEX PHARMACEUTICALS INC / MA	Sell $1.34M · 2,725 sh	2026-02-27	—
VRTXVERTEX PHARMACEUTICALS INC / MA	Sell $225.1K · 460 sh	2026-02-27	—
VRTXVERTEX PHARMACEUTICALS INC / MA	Sell $1.60M · 3,278 sh	2026-02-27	—
VRTXVERTEX PHARMACEUTICALS INC / MA	Sell $1.22M · 2,510 sh	2026-02-27	—

VRTXSell

2026-02-27 · VERTEX PHARMACEUTICALS INC / MA

$857.2K

—

VRTXSell

2026-02-27 · VERTEX PHARMACEUTICALS INC / MA

$2.97M

—

VRTXSell

2026-02-27 · VERTEX PHARMACEUTICALS INC / MA

$7.72M

—

VRTXSell

2026-02-27 · VERTEX PHARMACEUTICALS INC / MA

$1.73M

—

VRTXSell

2026-02-27 · VERTEX PHARMACEUTICALS INC / MA

$1.24M

—

VRTXSell

2026-02-27 · VERTEX PHARMACEUTICALS INC / MA

$466.2K

—

VRTXSell

2026-02-27 · VERTEX PHARMACEUTICALS INC / MA

$1.34M

—

VRTXSell

2026-02-27 · VERTEX PHARMACEUTICALS INC / MA

$225.1K

—

VRTXSell

2026-02-27 · VERTEX PHARMACEUTICALS INC / MA

$1.60M

—

VRTXSell

2026-02-27 · VERTEX PHARMACEUTICALS INC / MA

$1.22M

—

Newest 10 of 22 filings·Every Form 4 on record, with outcomesPro →

Filing in the same companies

Other insiders active in these names in the last 3 years

SB

Sachs Bruce I

VRTX · last 2026-08-27

BC

Bozic Carmen

VRTX · last 2026-05-15

BM

Bunnage Mark E.

VRTX · last 2026-05-15

AK

Ambrose Kristen

VRTX · last 2026-02-26

AE

Atkinson Edward Morrow III

VRTX · last 2026-02-25

BJ

Biller Jonathan

VRTX · last 2026-02-25

Outcomes measure each position — the first buy in a stock and every buy within 182 days — against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.